Serum fetuin-A and RANKL levels in patients with early stage breast cancer

BACKGROUND: Breast cancer (BC) is the primary cause of mortality due to cancer in females around the world. Fetuin-A is known to increase metastases over signals and peroxisomes related with growing. Receptor activator of nuclear factor-kB ligand (RANKL) takes part in cell adhesion, and RANKL inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Afsar, Cigdem Usul, Aral, Hale, Can, Orçun, Can, Trabulus Didem, Karacetin, Didem, Ali, Nazlı Mehmet, Umar, Gursu Rıza, Karabulut, Senem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040193/
https://www.ncbi.nlm.nih.gov/pubmed/36987423
http://dx.doi.org/10.5937/jomb0-37386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040193/
https://www.ncbi.nlm.nih.gov/pubmed/36987423
http://dx.doi.org/10.5937/jomb0-37386

Ejemplares similares